Chambers is an award-winning journalist-turned-PR-professional who began her career as a business reporter/editor covering the North County community for Today’s Local News, a former Copley Press publication later rolled into the San Diego Union-Tribune (now UT San Diego). She has worked locally for the San Diego Daily Transcript and San Diego Business Journal, where she reported on the Randy “Duke” Cunningham scandal, advances in biomedical research and development and scientific breakthroughs at San Diego’s research institutes.

In 2010, Chambers crossed over to the so-called “dark side” (which she says isn’t so dark) to work in the public relations industry, still keeping tabs on the scientific community as an associate director of public relations and communications for the California Healthcare Institute (CHI), which advocates for the state’s biomedical community on issues such as redundant state facilities inspections, FDA drug and device user fees and basic research funding. In this role, she is responsible for CHI publications and communications, including social media, media relations and public affairs activities.

In 2013, Chambers joined Edward Lifesciences as a Global Communications Manager.

Articles

A look at how rare disease research is getting funded

<p>The world’s best-selling drugs lower cholesterol, reduce heartburn and treat depression. Pharmaceutical companies rake in tens of billions of dollars a year (Lipitor alone brought in $13.6 billion in global sales in 2006) by reaching millions of patients in the and others abroad. Meanwhile, patients with rare diseases and lesser known conditions wait on better treatments as companies find ways to make a profit on their drugs.